195 related articles for article (PubMed ID: 22257107)
1. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.
Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C
J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.
Menzin J; White LA; Friedman M; Nichols C; Menzin J; Hoesche J; Bergman GE; Jones C
Thromb Haemost; 2012 Apr; 107(4):662-72. PubMed ID: 22318400
[TBL] [Abstract][Full Text] [Related]
3. Use of blood products in patients with anticoagulant-related major bleeding: an analysis of inhospital outcomes.
Menzin J; Sussman M; Nichols C; Friedman M; Zbrozek A
Am J Health Syst Pharm; 2014 Oct; 71(19):1635-45. PubMed ID: 25225449
[TBL] [Abstract][Full Text] [Related]
4. Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
Qualls LG; Greiner MA; Eapen ZJ; Fonarow GC; Mills RM; Klaskala W; Hernandez AF; Curtis LH
Clin Cardiol; 2013 Dec; 36(12):757-65. PubMed ID: 24114926
[TBL] [Abstract][Full Text] [Related]
5. Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal.
Marshall AL; Levine M; Howell ML; Chang Y; Riklin E; Parry BA; Callahan RT; Okechukwu I; Ayres AM; Nahed BV; Goldstein JN
J Thromb Haemost; 2016 Feb; 14(2):324-30. PubMed ID: 26644327
[TBL] [Abstract][Full Text] [Related]
6. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
[TBL] [Abstract][Full Text] [Related]
7. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
Sandén P; Renlund H; Svensson PJ; Själander A
Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
[TBL] [Abstract][Full Text] [Related]
8. Reversal strategies and outcomes in patients with atrial fibrillation and warfarin-associated intracranial hemorrhage.
Singer DE; Borowsky LH; Regan S; Lee JW; Zint K; Franca LR; Goldstein JN
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104903. PubMed ID: 32689580
[TBL] [Abstract][Full Text] [Related]
9. Bleeding risks and response to therapy in patients with INR higher than 9.
Pagano MB; Chandler WL
Am J Clin Pathol; 2012 Oct; 138(4):546-50. PubMed ID: 23010709
[TBL] [Abstract][Full Text] [Related]
10. What to do when warfarin therapy goes too far.
Prasad S; Wootten MR; Kulinski N; Chapman SA
J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study.
Jaakkola S; Nuotio I; Kiviniemi TO; Virtanen R; Virta A; Airaksinen KEJ
Ann Med; 2018 Mar; 50(2):164-171. PubMed ID: 29156997
[TBL] [Abstract][Full Text] [Related]
12. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
13. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
[TBL] [Abstract][Full Text] [Related]
14. Optimal INR level for warfarin therapy after mechanical mitral valve replacement.
Kamthornthanakarn I; Krittayaphong R
BMC Cardiovasc Disord; 2019 Apr; 19(1):97. PubMed ID: 31023235
[TBL] [Abstract][Full Text] [Related]
15. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation.
Van Den Ham HA; Klungel OH; Leufkens HG; Van Staa TP
J Thromb Haemost; 2013 Jan; 11(1):107-15. PubMed ID: 23088617
[TBL] [Abstract][Full Text] [Related]
16. Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage.
Akhter M; Morotti A; Cohen AS; Chang Y; Ayres AM; Schwab K; Viswanathan A; Gurol ME; Anderson CD; Greenberg SM; Rosand J; Goldstein JN
Intern Emerg Med; 2018 Jun; 13(4):557-565. PubMed ID: 28573379
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.
Suh SY; Kang WC; Oh PC; Choi H; Moon CI; Lee K; Han SH; Ahn T; Choi IS; Shin EK
Heart Vessels; 2014 Sep; 29(5):578-83. PubMed ID: 23974943
[TBL] [Abstract][Full Text] [Related]
18. Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.
Lau WCY; Li X; Wong ICK; Man KKC; Lip GYH; Leung WK; Siu CW; Chan EW
J Thromb Haemost; 2017 Oct; 15(10):1923-1933. PubMed ID: 28748652
[TBL] [Abstract][Full Text] [Related]
19. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.
Goldstein JN; Thomas SH; Frontiero V; Joseph A; Engel C; Snider R; Smith EE; Greenberg SM; Rosand J
Stroke; 2006 Jan; 37(1):151-5. PubMed ID: 16306465
[TBL] [Abstract][Full Text] [Related]
20. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM;
J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
